CliffBio
small molecule

PIFELTRO

DORAVIRINE

Loss of exclusivityAugust 2032latest FDA-listed patent expiry
CompanyMERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC

Drug detail

Brand namePIFELTRO
Active ingredientDORAVIRINE
Strength100MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalAugust 2018
Marketing statusRX

Listed patents

PatentExpiresType
8486975August 2032substance, product

More from MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

PIFELTRO patent cliff — loss of exclusivity August 2032 | CliffBio